Statement Of Financial Position [Abstract]

Innate Pharma - Filing #5981200

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Intangible assets other than goodwill
EUR
416,000 EUR
Trade and other non-current receivables
9 328 EUR
10 554 EUR
Other non-current non-financial assets
575,000 EUR
87,000 EUR
Non-current assets
25 317 EUR
27 175 EUR
Current assets [abstract]
Trade and other current receivables
4 972 EUR
55 557 EUR
Cash and cash equivalents
66 396 EUR
70 605 EUR
84 225 EUR
Current assets
85 742 EUR
148 013 EUR
Assets
111 059 EUR
175 187 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 192 EUR
4 044 EUR
Share premium
390 979 EUR
384 255 EUR
Equity
336 893 EUR
390 979 EUR
4 192 EUR
1 018 EUR
1 045 EUR
8 834 EUR
27,000 EUR
49 471 EUR
51 901 EUR
329 323 EUR
7 570 EUR
1 009 EUR
384 255 EUR
4 044 EUR
514,000 EUR
495,000 EUR
54 151 EUR
272 213 EUR
58 103 EUR
615,000 EUR
819,000 EUR
379 637 EUR
4 011 EUR
204,000 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits
2 730 EUR
2 441 EUR
Non-current provisions
274,000 EUR
603,000 EUR
Non-current liabilities
69 243 EUR
83 650 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
207,000 EUR
171,000 EUR
Trade and other current payables
16 007 EUR
17 018 EUR
Current liabilities
32 982 EUR
39 636 EUR
Equity and liabilities
111 059 EUR
175 187 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.